News

Allogene Therapeutics (ALLO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Sol Strategies has shown operational progress and institutional traction, but remains entirely dependent on volatile Solana ...
Welcome to the ONGC Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most prominent ...
Recent trading activity from some of Wall Street's most-followed investors shows a clear pattern between some of the hottest ...
Asian stocks fell on Monday after President Donald Trump last week doubled tariffs on steel and aluminum, and accused China of violating last month's agreement to slash tit-for-tat levies.
Sebi has suspended LS Industries and key individuals from market participation amid allegations of stock price manipulation.
Welspun Corp's stock traded higher than the 5-day, 10-, 20-, 30-, 50-, 100-, 150-day and 200-day simple moving averages (SMAs ...